Enter your search terms:
Top

Investor FAQs

Investor FAQs

Where is Aquestive Therapeutics' corporate headquarters?
The Company’s headquarters are located at 30 Technology Drive, Warren, New Jersey.
Who are the members of Aquestive Therapeutics’ Board of Directors?
You can view our Board of Directors by visiting the Board of Directors section on our website.
Who are the members of Aquestive Therapeutics’ Management Team?

You can view our management team by visiting the Team

On which exchange is Aquestive Therapeutics listed and what is the ticker symbol?
Aquestive Therapeutics is traded on the NASDAQ Global Market under the symbol AQST.
Who is Aquestive Therapeutics’ independent registered public accounting firm?
Aquestive Therapeutics’ independent registered public accounting firm is KPMG.
Who is Aquestive Therapeutics’ legal counsel?
Aquestive Therapeutics’ legal counsel is Dechert LLP.
When is Aquestive Therapeutics’ fiscal year end?
Aquestive Therapeutics’ fiscal year end is December 31.
When did Aquestive Therapeutics go public?
Aquestive Therapeutics went public on July 24, 2018.
How can I obtain Aquestive Therapeutics’ investor relations materials?
You can obtain Aquestive Therapeutics’ investor relations material in the Investor Relations section of our website.
How can I purchase shares?
Shares can be purchased through a stockbroker of your choice.
Does Aquestive Therapeutics’ have a direct stock purchase plan?
Aquestive Therapeutics does not offer a direct stock purchase plan.
Does Aquestive Therapeutics pay dividends and have a dividend reinvestment program?
Currently, Aquestive Therapeutics does not offer a dividend or a dividend reinvestment program.
Who is Aquestive Therapeutics’ transfer agent and how do I contact them?

Investors should contact Aquestive Therapeutics’ transfer agent listed below. A transfer agent manages and maintains the records of a company’s shares.

Computershare Investor Services, LLC
www.computershare.com/investor
Written requests
Computershare
P.O. Box 505000
Louisville, KY 40233-5000

By overnight delivery:
Computershare
462 South 4th Street, Suite 1600
Louisville KY 40202

Telephone inquiries
1- 800-736-3001 (US, Canada, Puerto Rico)
1 -781-575-3001 (Non US)

How can I get a copy of your Annual Report or any other Investor materials (i.e., Investor Relations kit, 10-k)?
Quarterly & Annual Reports and other investor materials are available under the SEC filings page of the investor relations section of the corporate website. Additionally, all SEC filings can also be accessed directly from the SEC website.
Where can I find recent Aquestive Therapeutics’ press releases?
You can view our recent press releases by visiting the Newsroom section of our website.
Who can I contact if I am a member of the media?
If you have a media related inquiries, please contact Christopher Hippolyte at Syneos Health at +1-212-364-0458 or christopher.hippolyte@syneoshealth.com.
Where can I find more information on Aquestive Therapeutics’ R&D programs?
You can view Aquestive Therapeutics’ R&D plans by visiting the Pipeline section of our website.
If I have questions regarding Aquestive Therapeutics that have not been answered, whom should I contact?
For investor relations questions or other inquiries, please contact Stephanie Carrington at ICR Inc. at +1-646-277-1282 or stephanie.carrington@icrinc.com.
Email Alerts
Investor Contact
Investor FAQs
RSS Feeds